This article was last updated on April 16, 2022
Canada: 
Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
USA: Oye! Times readers Get FREE $30 to spend on Amazon, Walmart…
A Canadian study to test the professed “liberation treatment” on multiple sclerosis patients has been granted the compulsory medical and ethical approvals for its commencement. The medical director of the UBC Hospital MS Clinic, Dr. Anthony Traboulsee, was granted ethical support from institutions in British Columbia and Québec and is now planning to start the process of initiating the clinical trial.
The primary purpose of the study is to conclude safety while executing angioplasty to open neck and chest veins, and it will also help find out the safety of monitoring the affect of the procedure on MS patients. Dr Traboulsee stated on Friday that “this pan Canadian controlled study will allow us to monitor MS patients over a two-year period and obtain scientific evidence on the safety and efficacy of the CCSVI procedure in the long term.” Recruitment for case study patients will start from 1st of November, 2012.
An estimate of 100 patients is likely to participate in the trial, scheduled to be conducted in British Columbia and Québec. This study is going to be a joint effort of the Canadian Institutes of Health Research (CIHR), the MS Society of Canada, along with destination provinces. It is calculated that overall the study will cost $6 million.
Previously a total of seven studies have already been commenced and are still ongoing in North America, sponsored by the MS Society of Canada and its U.S. counterpart, which are also concluding whether vein abnormalities and MS are linked or not.
Be the first to comment